SCHEMBL25623992

SCHEMBL25623992

Cc1ccc(N(c2ccc(C)cc2)c2ccc(-c3ccc(C)c4ccccc34)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.46
COMT P21964 1/20 0.41
CYP2A6 P11509 1/20 0.37
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
PRKDC P78527 1/20 0.35
CRHR1 P34998 1/20 0.35
MCL1 Q07820 1/20 0.35
ALDH1A1 P00352 4/20 0.34
TSHR P16473 1/20 0.34
CYP2C19 P33261 1/20 0.34
MAPT P10636 5/20 0.34
KDM4E B2RXH2 3/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
PABPC1 P11940 1/20 0.34
HPGD P15428 2/20 0.34
POLB P06746 2/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL401706 0.95 CYP1A2 (0.42) CYP1A2COMTCYP2A6KMT2AMEN1
SCHEMBL10041934 0.95 CYP1A2 (0.42) CYP1A2COMTCYP2A6KMT2AMEN1
SCHEMBL12619657 0.89 TSHR (0.43) CYP1A2COMTKMT2AMEN1NPC1
SCHEMBL21109108 0.89 CYP1A2 (0.59) CYP1A2COMTCYP2A6KMT2AMEN1
SCHEMBL15133378 0.88 CYP1A2 (0.45) CYP1A2CYP2A6KMT2AMEN1RAB9A
SCHEMBL13658640 0.86 COMT (0.41) COMTKMT2AMEN1NPC1RAB9A
SCHEMBL13658643 0.84 COMT (0.40) COMTKMT2AMEN1NPC1RAB9A
SCHEMBL15234682 0.83 CYP1A2 (0.34) CYP1A2COMTKMT2AMEN1NPC1
SCHEMBL13900009 0.81 COMT (0.40) COMTKMT2AMEN1NPC1RAB9A
SCHEMBL13899988 0.81 COMT (0.40) COMTKMT2AMEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240217902-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2024-07-04 US disclosed
US-11877508-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-01-16 US disclosed
US-20230200214-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-06-22 US disclosed
US-20230189636-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230189636-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF EMC1, EMC2, EPCAM CYP1A2 1633/4885COMT 2327/4885CYP2A6 2104/4885
US-20230200214-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF EMC1, EMC2, EPCAM CYP1A2 1633/4885COMT 2327/4885CYP2A6 2104/4885
US-11877508-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof EMC1, EMC2, EPCAM CYP1A2 1633/4885COMT 2327/4885CYP2A6 2104/4885
US-20240217902-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF EMC1, EMC2, AOC1 CYP1A2 1643/4885COMT 2452/4885CYP2A6 2151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.